ClinicalTrials.gov record
Completed Phase 2 Interventional

New Medications to Treat Alcohol Dependence

ClinicalTrials.gov ID: NCT00223639

Public ClinicalTrials.gov record NCT00223639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00223639
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bankole Johnson
Other
Enrollment
29 participants

Conditions and interventions

Conditions

Interventions

  • Topiramate Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Jun 30, 2008
Completion
Jun 30, 2008
Last update posted
Feb 6, 2012

2005 – 2008

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
2
Facility City State ZIP Site status
UVA CARE Charlottesville Virginia 22911
UVA CARE Richmond Richmond Virginia 23294

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00223639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2012 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00223639 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →